Galena BiopharmaInc (NASDAQ:GALE)’s shares gained 4.33% to $3.13. The company announced that Mark W. Schwartz, Ph.D., Executive Vice President and Chief Operating Officer will present a...
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares gained 5.92% to $7.13. The company on Jan. 17 announced the commercial availability of Iclusig® (ponatinib) for adult patients with refractory...